These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24216511)

  • 1. Allogeneic T cell responses are regulated by a specific miRNA-mRNA network.
    Sun Y; Tawara I; Zhao M; Qin ZS; Toubai T; Mathewson N; Tamaki H; Nieves E; Chinnaiyan AM; Reddy P
    J Clin Invest; 2013 Nov; 123(11):4739-54. PubMed ID: 24216511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice.
    Wu Y; Heinrichs J; Bastian D; Fu J; Nguyen H; Schutt S; Liu Y; Jin J; Liu C; Li QJ; Xia C; Yu XZ
    Blood; 2015 Sep; 126(11):1314-23. PubMed ID: 26138686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
    Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.
    Levy RB; Jones M; Hamilton BL; Paupe J; Horowitz T; Riley R
    J Immunol; 1995 Jan; 154(1):106-15. PubMed ID: 7995931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ-derived dendritic cells have differential effects on alloreactive T cells.
    Kim TD; Terwey TH; Zakrzewski JL; Suh D; Kochman AA; Chen ME; King CG; Borsotti C; Grubin J; Smith OM; Heller G; Liu C; Murphy GF; Alpdogan O; van den Brink MR
    Blood; 2008 Mar; 111(5):2929-40. PubMed ID: 18178870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.
    Ichiba T; Teshima T; Kuick R; Misek DE; Liu C; Takada Y; Maeda Y; Reddy P; Williams DL; Hanash SM; Ferrara JL
    Blood; 2003 Jul; 102(2):763-71. PubMed ID: 12663442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mature T cell responses are controlled by microRNA-142.
    Sun Y; Oravecz-Wilson K; Mathewson N; Wang Y; McEachin R; Liu C; Toubai T; Wu J; Rossi C; Braun T; Saunders T; Reddy P
    J Clin Invest; 2015 Jul; 125(7):2825-40. PubMed ID: 26098216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Coding RNA Mediated Regulation of Allogeneic T Cell Responses After Hematopoietic Transplantation.
    Peltier D; Reddy P
    Front Immunol; 2018; 9():1110. PubMed ID: 29963039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation.
    Lee CW; Wohlan K; Dallmann I; Förster R; Ganser A; Krueger A; Scherr M; Eder M; Koenecke C
    J Immunol; 2016 May; 196(9):3927-34. PubMed ID: 27009493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes.
    Wang WX; Wilfred BR; Hu Y; Stromberg AJ; Nelson PT
    RNA; 2010 Feb; 16(2):394-404. PubMed ID: 20042474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Expression of Long Noncoding RNAs During Cardiac Allograft Rejection.
    Gu G; Huang Y; Wu C; Guo Z; Ma Y; Xia Q; Awasthi A; He X
    Transplantation; 2017 Jan; 101(1):83-91. PubMed ID: 27575691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
    Davis JE; Harvey M; Gherardin NA; Koldej R; Huntington N; Neeson P; Trapani JA; Ritchie DS
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):242-9. PubMed ID: 25459639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis.
    Jiang Z; Podack E; Levy RB
    Blood; 2001 Jul; 98(2):390-7. PubMed ID: 11435308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation.
    Ewing P; Hildebrandt GC; Planke S; Andreesen R; Holler E; Gerbitz A
    Int J Mol Med; 2007 Sep; 20(3):301-8. PubMed ID: 17671733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients.
    Marks L; Altman NH; Podack ER; Levy RB
    Transplantation; 2004 Mar; 77(6):804-12. PubMed ID: 15077018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism.
    Martin PJ
    Blood; 1996 Aug; 88(3):962-9. PubMed ID: 8704255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
    Clement JD; Chan SY; Bishop DK
    Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia.
    Weiss L; Nusair S; Reich S; Sidi H; Slavin S
    Cancer Immunol Immunother; 1996 Oct; 43(2):103-8. PubMed ID: 8954144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.